Research Article | | Peer-Reviewed

Effects of Changes in Estimated Pulse Wave Velocity Trajectory on Cognitive Function in Middle-Aged and Elderly Patients with Cardiovascular Disease

Received: 10 September 2025     Accepted: 18 October 2025     Published: 29 October 2025
Views:       Downloads:
Abstract

This study aimed to investigate the impact of estimated pulse wave velocity (ePWV) trajectory on cognitive function in middle-aged and elderly patients with cardiovascular disease (CVD). A retrospective cohort of 2,420 middle-aged and elderly patients with CVD from the Charls database between 2011 and 2015 was included. A cohort trajectory model was used to analyze ePWV trajectory. Univariate and multivariate logistic regression analyses were performed to analyze factors influencing cognitive function, and receiver operating characteristic (ROC) curves were used to assess the predictive power of ePWV trajectory on cognitive function. Subgroup analyses were performed to explore the interaction between various factors and ePWV trajectory on cognitive function. Results showed that 455 participants developed severe cognitive impairment. Among the ePWV trajectory groups, 23.52% of participants in the low-to-increasing group, 45.05% in the moderate-to-increasing group, and 31.43% in the high-to-increasing group experienced cognitive decline. Changes in ePWV trajectory were significantly associated with cognitive decline (P < 0.05), particularly in the high-to-increasing group (OR = 4.16, 95% CI: 3.122-5.549, Model 1; OR = 1.96, 95% CI: 1.269-3.021, Model 3; OR = 1.59, 95% CI: 1.007-2.498). Receiver operating characteristic (ROC) results showed that the area under the curves (AUCs) for Models 1, 2, and 3 were 0.628, 0.713, and 0.785, respectively. Subgroup analysis revealed that educational level, age, systolic blood pressure, and BMI were significantly associated with cognitive function (P < 0.05). Except for BMI, no significant interactions between ePWV trajectory and other subgroup variables on cognitive function were observed (P > 0.05). Therefore, this study believes that changes in ePWV trajectory are closely related to cognitive decline in middle-aged and elderly patients with cardiovascular disease, and this indicator may serve as an economical and effective indicator for assessing severe cognitive impairment in middle-aged and elderly patients with CVD.

Published in Science Discovery (Volume 13, Issue 5)
DOI 10.11648/j.sd.20251305.12
Page(s) 86-94
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2025. Published by Science Publishing Group

Keywords

Pulse Wave Velocity, Cardiovascular Diseases, Cognitive Function, Group-based Trajectory Model

References
[1] 中国心血管健康与疾病报告2023概要[J].中国循环杂志, 2024, 39(07): 625-660.
[2] Zhu M, Jin W, He W, et al. The incidence, mortality and disease burden of cardiovascular diseases in China: a comparative study with the United States and Japan based on the GBD 2019 time trend analysis[J]. Frontiers in Cardiovascular Medicine, 2024, 11: 1408487.
[3] Van den Bussche H, Koller D, Kolonko T, et al. Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims data based cross-sectional study in Germany[J]. BMC public health, 2011, 11(1): 101.
[4] Wiesmann M, Kiliaan A J, Claassen J A H R. Vascular aspects of cognitive impairment and dementia[J]. Journal of Cerebral Blood Flow & Metabolism, 2013, 33(11): 1696-1706.
[5] Abete P, Della-Morte D, Gargiulo G, et al. Cognitive impairment and cardiovascular diseases in the elderly. A heart–brain continuum hypothesis[J]. Ageing research reviews, 2014, 18: 41-52.
[6] Van Nieuwkerk A C, Delewi R, Wolters F J, et al. Cognitive impairment in patients with cardiac disease: implications for clinical practice[J]. Stroke, 2023, 54(8): 2181-2191.
[7] Jia X, Wang Z, Huang F, et al. A comparison of the Mini-Mental State Examination (MMSE) with the Montreal Cognitive Assessment (MoCA) for mild cognitive impairment screening in Chinese middle-aged and older population: a cross-sectional study[J]. BMC psychiatry, 2021, 21(1): 485.
[8] Saji M, Higuchi R, Saitoh M, et al. Modified essential frailty toolset to determine outcomes following transcatheter aortic valve replacement[J]. Journal of Cardiology, 2021, 77(4): 341-345.
[9] Zhuang L, Yang Y, Gao J. Cognitive assessment tools for mild cognitive impairment screening[J]. Journal of Neurology, 2021, 268(5): 1615-1622.
[10] Santabárbara J, Gracia-García P, Pírez G, et al. Mortality in mild cognitive impairment diagnosed with DSM-5 criteria and with Petersen's criteria: A 17-year follow-up in a community study[J]. The American Journal of Geriatric Psychiatry, 2016, 24(11): 977-986.
[11] Qin J, He Z, Wu L, et al. Prevalence of mild cognitive impairment in patients with hypertension: a systematic review and meta-analysis[J]. Hypertension Research, 2021, 44(10): 1251-1260.
[12] Stone K, Fryer S, Faulkner J, et al. Acute changes in carotid-femoral pulse-wave velocity are tracked by heart-femoral pulse-wave velocity[J]. Frontiers in Cardiovascular Medicine, 2021, 7: 592834.
[13] Greve S V, Blicher M K, Kruger R, et al. Estimated carotid–femoral pulse wave velocity has similar predictive value as measured carotid–femoral pulse wave velocity[J]. Journal of hypertension, 2016, 34(7): 1279-1289.
[14] Li J, Ren Y, Wang L, et al. Estimated pulse wave velocity associated with cognitive phenotypes in a rural older population in China: A cohort study[J]. Alzheimer's & Dementia, 2025, 21(2): e14491.
[15] Chen Y, Xu Z, Guo Y, et al. Air pollution increases the risk of frailty: China Health and Retirement Longitudinal Study (CHARLS)[J]. Journal of Hazardous Materials, 2025, 492: 138105.
[16] Fung K W, Xu J, Bodenreider O. The new International Classification of Diseases 11th edition: a comparative analysis with ICD-10 and ICD-10-CM[J]. Journal of the American Medical Informatics Association, 2020, 27(5): 738-746.
[17] Hugo J, Ganguli M. Dementia and cognitive impairment: epidemiology, diagnosis, and treatment[J]. Clinics in geriatric medicine, 2014, 30(3): 421.
[18] Rennemark M, Berglund J. Decreased cognitive functions at the age of 66, as measured by the MMSE, associated with having left working life before the age of 60: Results from the SNAC study[J]. Scandinavian journal of public health, 2014, 42(3): 304-309.
[19] 刘春晓, 朱盼盼, 余爱花, 等. 血清NCAM、Netrin-1在首发精神分裂症患者中的表达及与PANSS评分的相关性 [J]. 海南医学, 2025, 36(03): 343-347.
[20] Okonkwo O C, Cohen R A, Gunstad J, et al. Longitudinal trajectories of cognitive decline among older adults with cardiovascular disease[J]. Cerebrovascular diseases, 2010, 30(4): 362-373.
[21] Zachara R, Właszczuk A, Gorzkowska A, et al. The influence of hypertension, diabetes, lipid disorders and the presence of the APOE4 allele on the cognitive functions of patients over 65 years of age[J]. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego, 2022, 50(300): 391-394. PMID: 36645688.
[22] Casagrande S S, Lee C, Stoeckel L E, et al. Cognitive function among older adults with diabetes and prediabetes, NHANES 2011–2014[J]. Diabetes research and clinical practice, 2021, 178: 108939.
[23] Mun H, Shim J Y, Kimm H, et al. Associations between Korean coronary Heart disease risk score and cognitive function in dementia-free Korean older adults[J]. Journal of Korean Medical Science, 2023, 38(2).
[24] Cukierman-Yaffe T, McClure L A, Risoli T, et al. The relationship between glucose control and cognitive function in people with diabetes after a lacunar stroke[J]. The Journal of Clinical Endocrinology & Metabolism, 2021, 106(4): 1521-1528.
[25] Johansen M C, Langton-Frost N, Gottesman R F. The role of cardiovascular disease in cognitive impairment[J]. Current Geriatrics Reports, 2020, 9(1): 1-9.
[26] Liao G, He C, Li X, et al. Exploring the heart-brain and brain-heart axes: Insights from a bidirectional Mendelian randomization study on brain cortical structure and cardiovascular disease[J]. Neurobiology of Disease, 2024, 200: 106636.
[27] Bink D I, Ritz K, Aronica E, et al. Mouse models to study the effect of cardiovascular risk factors on brain structure and cognition [J]. Journal of Cerebral Blood Flow & Metabolism, 2013, 33(11): 1666-1684.
[28] Greco S, Zaccagnini G, Fuschi P, et al. Increased BACE1-AS long noncoding RNA and β-amyloid levels in heart failure[J]. Cardiovascular research, 2017, 113(5): 453-463.
[29] Herzog M J, Müller P, Lechner K, et al. Arterial stiffness and vascular aging: mechanisms, prevention, and therapy[J]. Signal transduction and targeted therapy, 2025, 10(1): 282.
[30] Regnault V, Lacolley P, Laurent S. Arterial stiffness: from basic primers to integrative physiology[J]. Annual Review of Physiology, 2024, 86(1): 99-121.
[31] Li Q, Tan J, Qin Q Z, et al. Association between arterial stiffness and MASLD in US young adults: base on NHANES 2005-2018 [J]. American Journal of Preventive Cardiology, 2025: 101003.
[32] Aimagambetova B, Ariko T, Gardener H, et al. Association of estimated pulse wave velocity with cognitive function in a multiethnic diverse population: The Northern Manhattan Study [J]. Alzheimer's & dementia, 2024, 20(7): 4903-4913.
[33] Hao P, Feng S, Suo M, et al. Estimated pulse wave velocity and cognitive outcomes: a post hoc analysis of SPRINT-MIND[J]. American Journal of Hypertension, 2024, 37(7): 485-492.
[34] Heffernan K S, Stoner L, Meyer M L, et al. Association between estimated pulse wave velocity and cognitive performance in older black and white adults in NHANES[J]. Journal of Alzheimer’s Disease, 2022, 88(3): 985-993.
[35] Heffernan K S, Stoner L, London A S, et al. Estimated pulse wave velocity as a measure of vascular aging[J]. PLoS One, 2023, 18(1): e0280896.
Cite This Article
  • APA Style

    Zhao, J. (2025). Effects of Changes in Estimated Pulse Wave Velocity Trajectory on Cognitive Function in Middle-Aged and Elderly Patients with Cardiovascular Disease. Science Discovery, 13(5), 86-94. https://doi.org/10.11648/j.sd.20251305.12

    Copy | Download

    ACS Style

    Zhao, J. Effects of Changes in Estimated Pulse Wave Velocity Trajectory on Cognitive Function in Middle-Aged and Elderly Patients with Cardiovascular Disease. Sci. Discov. 2025, 13(5), 86-94. doi: 10.11648/j.sd.20251305.12

    Copy | Download

    AMA Style

    Zhao J. Effects of Changes in Estimated Pulse Wave Velocity Trajectory on Cognitive Function in Middle-Aged and Elderly Patients with Cardiovascular Disease. Sci Discov. 2025;13(5):86-94. doi: 10.11648/j.sd.20251305.12

    Copy | Download

  • @article{10.11648/j.sd.20251305.12,
      author = {Jinfeng Zhao},
      title = {Effects of Changes in Estimated Pulse Wave Velocity Trajectory on Cognitive Function in Middle-Aged and Elderly Patients with Cardiovascular Disease
    },
      journal = {Science Discovery},
      volume = {13},
      number = {5},
      pages = {86-94},
      doi = {10.11648/j.sd.20251305.12},
      url = {https://doi.org/10.11648/j.sd.20251305.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sd.20251305.12},
      abstract = {This study aimed to investigate the impact of estimated pulse wave velocity (ePWV) trajectory on cognitive function in middle-aged and elderly patients with cardiovascular disease (CVD). A retrospective cohort of 2,420 middle-aged and elderly patients with CVD from the Charls database between 2011 and 2015 was included. A cohort trajectory model was used to analyze ePWV trajectory. Univariate and multivariate logistic regression analyses were performed to analyze factors influencing cognitive function, and receiver operating characteristic (ROC) curves were used to assess the predictive power of ePWV trajectory on cognitive function. Subgroup analyses were performed to explore the interaction between various factors and ePWV trajectory on cognitive function. Results showed that 455 participants developed severe cognitive impairment. Among the ePWV trajectory groups, 23.52% of participants in the low-to-increasing group, 45.05% in the moderate-to-increasing group, and 31.43% in the high-to-increasing group experienced cognitive decline. Changes in ePWV trajectory were significantly associated with cognitive decline (P P P > 0.05). Therefore, this study believes that changes in ePWV trajectory are closely related to cognitive decline in middle-aged and elderly patients with cardiovascular disease, and this indicator may serve as an economical and effective indicator for assessing severe cognitive impairment in middle-aged and elderly patients with CVD.
    },
     year = {2025}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Effects of Changes in Estimated Pulse Wave Velocity Trajectory on Cognitive Function in Middle-Aged and Elderly Patients with Cardiovascular Disease
    
    AU  - Jinfeng Zhao
    Y1  - 2025/10/29
    PY  - 2025
    N1  - https://doi.org/10.11648/j.sd.20251305.12
    DO  - 10.11648/j.sd.20251305.12
    T2  - Science Discovery
    JF  - Science Discovery
    JO  - Science Discovery
    SP  - 86
    EP  - 94
    PB  - Science Publishing Group
    SN  - 2331-0650
    UR  - https://doi.org/10.11648/j.sd.20251305.12
    AB  - This study aimed to investigate the impact of estimated pulse wave velocity (ePWV) trajectory on cognitive function in middle-aged and elderly patients with cardiovascular disease (CVD). A retrospective cohort of 2,420 middle-aged and elderly patients with CVD from the Charls database between 2011 and 2015 was included. A cohort trajectory model was used to analyze ePWV trajectory. Univariate and multivariate logistic regression analyses were performed to analyze factors influencing cognitive function, and receiver operating characteristic (ROC) curves were used to assess the predictive power of ePWV trajectory on cognitive function. Subgroup analyses were performed to explore the interaction between various factors and ePWV trajectory on cognitive function. Results showed that 455 participants developed severe cognitive impairment. Among the ePWV trajectory groups, 23.52% of participants in the low-to-increasing group, 45.05% in the moderate-to-increasing group, and 31.43% in the high-to-increasing group experienced cognitive decline. Changes in ePWV trajectory were significantly associated with cognitive decline (P P P > 0.05). Therefore, this study believes that changes in ePWV trajectory are closely related to cognitive decline in middle-aged and elderly patients with cardiovascular disease, and this indicator may serve as an economical and effective indicator for assessing severe cognitive impairment in middle-aged and elderly patients with CVD.
    
    VL  - 13
    IS  - 5
    ER  - 

    Copy | Download

Author Information
  • School of Public Health, Zhengzhou University, Zhengzhou, China

  • Sections